🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open label, randomized phase II study designed to evaluate the t...
Status
Terminated
Location
Stanford University Hospitals and Clinics
Start Date
2007-04
Trial ID
NCT00476554
Treatments Being Tested
This is a combination study to evaluate sapacitabine administered in altern...
Status
Unknown
Location
Rush University Medical Center
Start Date
2010-06-17
Trial ID
NCT01211457
A study of sequential administration of oral sapacitabine and oral Selicicl...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2009-04
Trial ID
NCT00999401
Treatments Being Tested
This Phase 3 study assesses two drug regimens as the initial treatment of p...
Status
Completed
Location
University of Alabama Comprehensive Cancer Center
Start Date
2011-10-01
Trial ID
NCT01303796
Treatments Being Tested
This research study is studying a combination of drugs as a possible treatm...
Status
Active Not Recruiting
Location
Dana Farber Cancer Institute
Start Date
2018-10-01
Trial ID
NCT03641755
Treatments Being Tested
A phase II study to evaluate the safety and efficacy of oral sapacitabine i...
Status
Terminated
Location
Rush University Medical Center
Start Date
2008-12-01
Trial ID
NCT00885963
Treatments Being Tested
The goal of this clinical research study is to learn if sapacitabine given ...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2011-08-22
Trial ID
NCT01253460
Treatments Being Tested
The objective is to treat elderly AML and MDS patients with sapacitabine....
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2007-12
Trial ID
NCT00590187
The goal of this safety/pharmacology study is to determine MTD of sapacitab...
Status
Completed
Location
The University of Texas MD Anderson Cancer Center
Start Date
2006-01
Trial ID
NCT00380653
Treatments Being Tested